Monogenic disorders in short children born SGA with normal head circumference
Syndrome [OMIM] . | Genetic defect . | Inheritance . | Incidence . | Mean BW/BL SDS . | Clinical features . | Laboratory data . | Treatment . |
---|---|---|---|---|---|---|---|
Monogenic disorders with normal head circumference and proportionate short stature | |||||||
GH deficiency | GH1, GHRHR, BTK | AR, AD X-linked | 1:5.000 | −0.9/−0.6 | Wide variation in height deficit | ↓GH peak during GH stimulation test, ↓IGF-I, ↓IGFBP-3, ↓ALS | GH treatment |
Laron syndrome [262500] | GHR | AR or rarely AD | ≈500 cases | −0.6/−1.6 | Wide variation in height, midfacial hypoplasia | ↑GH, ↓IGF-I, ↓IGFBP-3, ↓ALS, variable GHBP | IGF-I treatment moderately effective |
ALS deficiency [615961] | IGFALS | AR | ≈65 cases | −2.2 | Mild to moderate short stature | ↓IGF-I, ↓IGFBP-3, ↓ALS | No data |
3-M syndrome [273750, 612921, 614205] | CUL7, OBSL1, CCDC8 | AR | ≈200 cases | −3.1 | Facial features, normal mental development, long and slender tubular bones, reduced AP diameter of vertebral bodies, delayed bone age | Nl GH, IGF-I, IGFBP-3 | Effect of GH considered insufficient |
Silver-Russell variant [616489] | IGF2 | AD, paternal | 8 cases | −3.9/−4.6 | Dysmorphic features like SRS, fulfilling the Netchine-Harbison criteria for SRS, including relative macrocephaly | ↑/normal GH, normal IGF-I, ↑/normal IGFBP-3, ↓ IGF-II | GH treatment likely as effective as in other genetic variants of SRS |
Floating Harbor syndrome [136140] | SCRAP | AD | ≈52 cases | −2.5 | Proportionate short stature, delayed bone age and speech, triangular face, deep-set eyes, long eyelashes, bulbous nose, wide columella, short philtrum, thin lips | GH deficiency described in some patients. ↑/normal IGF-I (mainly during rhGH treatment. Nl IGFBP-3 | Insufficient data |
Noonan syndrome [163950] | PTPN11 and 12 other genes | AD or rarely AR | 1:1.000-2.500 | −1.0 | Short stature, facial dysmorphism, wide spectrum of congenital heart defects, pectus deformity, cryptorchidism, coagulation defect | Nl GH, IGFBP-3 ↓/normal IGF-I | GH treatment registered in US and EU |
Monogenic disorders with normal head circumference and disproportionate short stature | |||||||
SHOX-associated short stature [300582] | SHOX | AD | 2-17% of short stature | −0.4 −1.1 | Short forearm and lower leg, bowing of forearm and tibia, dislocation of ulna at elbow, Madelung deformity, muscular hypertrophy, radiologic signs at wrist and forearm | Nl GH, IGF-I, IGFBP-3 | GH has similar efficacy as in Turner syndrome; registered in many countries |
Achondroplasia [100800] | Act FGFR3 | AD | 1:15.000-40.000 | −0.7/−1.0 | Rhizomelic limb shortening, frontal bossing, midface hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, genu varum, trident hand | Nl GH, IGF-I, IGFBP-3 | Effects of GH considered insufficient |
Hypochondro-plasia [146000] | Act FGFR3 | 1:15.000-40.000 | — | Rhizomelic limb shortening, limitation of elbow extension, brachydactyly, relative macrocephaly, generalized laxity, specific radiologic features | Nl GH, IGF-I, IGFBP-3 | Effect of GH considered insufficient | |
Short stature with nonspecific skeletal abnormalities [616255] | NPR2 | AD | 1-2% of short SGA and ISS | −0.8/−2.3 | ↑ sitting height/height ratio, shortening of metacarpals, phenotypic or radiographic indicators of SHOX HI (but no Madelung deformity) | Nl GH, IGF-I, IGFBP-3 | Insufficient data |
Brachydactyly type A1 [1112500] | IHH | AD | 1.6% of short SGA and ISS | −/−1.4 | ↑ sitting height/height ratio, shortening of middle phalanx of 2nd and 5th fingers with cone-shaped epiphyses | Nl GH, IGF-I, IGFBP-3 | Preliminary data GH treatment positive |
Short stature/early-onset osteoarthritis or osteochondritis [165800] | ACAN | AD | 1%-2% of short SGA and ISS | −0.7/−1.5 | Proportionate or disproportionate short stature, with or without advanced bone age, brachydactyly, early-onset osteoarthritis | Nl GH, IGF-I, IGFBP-3 | Insufficient data |
Syndrome [OMIM] . | Genetic defect . | Inheritance . | Incidence . | Mean BW/BL SDS . | Clinical features . | Laboratory data . | Treatment . |
---|---|---|---|---|---|---|---|
Monogenic disorders with normal head circumference and proportionate short stature | |||||||
GH deficiency | GH1, GHRHR, BTK | AR, AD X-linked | 1:5.000 | −0.9/−0.6 | Wide variation in height deficit | ↓GH peak during GH stimulation test, ↓IGF-I, ↓IGFBP-3, ↓ALS | GH treatment |
Laron syndrome [262500] | GHR | AR or rarely AD | ≈500 cases | −0.6/−1.6 | Wide variation in height, midfacial hypoplasia | ↑GH, ↓IGF-I, ↓IGFBP-3, ↓ALS, variable GHBP | IGF-I treatment moderately effective |
ALS deficiency [615961] | IGFALS | AR | ≈65 cases | −2.2 | Mild to moderate short stature | ↓IGF-I, ↓IGFBP-3, ↓ALS | No data |
3-M syndrome [273750, 612921, 614205] | CUL7, OBSL1, CCDC8 | AR | ≈200 cases | −3.1 | Facial features, normal mental development, long and slender tubular bones, reduced AP diameter of vertebral bodies, delayed bone age | Nl GH, IGF-I, IGFBP-3 | Effect of GH considered insufficient |
Silver-Russell variant [616489] | IGF2 | AD, paternal | 8 cases | −3.9/−4.6 | Dysmorphic features like SRS, fulfilling the Netchine-Harbison criteria for SRS, including relative macrocephaly | ↑/normal GH, normal IGF-I, ↑/normal IGFBP-3, ↓ IGF-II | GH treatment likely as effective as in other genetic variants of SRS |
Floating Harbor syndrome [136140] | SCRAP | AD | ≈52 cases | −2.5 | Proportionate short stature, delayed bone age and speech, triangular face, deep-set eyes, long eyelashes, bulbous nose, wide columella, short philtrum, thin lips | GH deficiency described in some patients. ↑/normal IGF-I (mainly during rhGH treatment. Nl IGFBP-3 | Insufficient data |
Noonan syndrome [163950] | PTPN11 and 12 other genes | AD or rarely AR | 1:1.000-2.500 | −1.0 | Short stature, facial dysmorphism, wide spectrum of congenital heart defects, pectus deformity, cryptorchidism, coagulation defect | Nl GH, IGFBP-3 ↓/normal IGF-I | GH treatment registered in US and EU |
Monogenic disorders with normal head circumference and disproportionate short stature | |||||||
SHOX-associated short stature [300582] | SHOX | AD | 2-17% of short stature | −0.4 −1.1 | Short forearm and lower leg, bowing of forearm and tibia, dislocation of ulna at elbow, Madelung deformity, muscular hypertrophy, radiologic signs at wrist and forearm | Nl GH, IGF-I, IGFBP-3 | GH has similar efficacy as in Turner syndrome; registered in many countries |
Achondroplasia [100800] | Act FGFR3 | AD | 1:15.000-40.000 | −0.7/−1.0 | Rhizomelic limb shortening, frontal bossing, midface hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, genu varum, trident hand | Nl GH, IGF-I, IGFBP-3 | Effects of GH considered insufficient |
Hypochondro-plasia [146000] | Act FGFR3 | 1:15.000-40.000 | — | Rhizomelic limb shortening, limitation of elbow extension, brachydactyly, relative macrocephaly, generalized laxity, specific radiologic features | Nl GH, IGF-I, IGFBP-3 | Effect of GH considered insufficient | |
Short stature with nonspecific skeletal abnormalities [616255] | NPR2 | AD | 1-2% of short SGA and ISS | −0.8/−2.3 | ↑ sitting height/height ratio, shortening of metacarpals, phenotypic or radiographic indicators of SHOX HI (but no Madelung deformity) | Nl GH, IGF-I, IGFBP-3 | Insufficient data |
Brachydactyly type A1 [1112500] | IHH | AD | 1.6% of short SGA and ISS | −/−1.4 | ↑ sitting height/height ratio, shortening of middle phalanx of 2nd and 5th fingers with cone-shaped epiphyses | Nl GH, IGF-I, IGFBP-3 | Preliminary data GH treatment positive |
Short stature/early-onset osteoarthritis or osteochondritis [165800] | ACAN | AD | 1%-2% of short SGA and ISS | −0.7/−1.5 | Proportionate or disproportionate short stature, with or without advanced bone age, brachydactyly, early-onset osteoarthritis | Nl GH, IGF-I, IGFBP-3 | Insufficient data |
Abbreviations: act, activating; AD, autosomal dominant; ALS, acid labile subunit; AR, autosomal recessive; BL, birth length; BW, birth weight; GH, growth hormone; IGF, insulin-like growth factor; IGFBP, IGF binding protein; ISS, idiopathic short stature; SDS, standard deviation score; SGA, small for gestational age; SRS, Silver-Russell syndrome.
Monogenic disorders in short children born SGA with normal head circumference
Syndrome [OMIM] . | Genetic defect . | Inheritance . | Incidence . | Mean BW/BL SDS . | Clinical features . | Laboratory data . | Treatment . |
---|---|---|---|---|---|---|---|
Monogenic disorders with normal head circumference and proportionate short stature | |||||||
GH deficiency | GH1, GHRHR, BTK | AR, AD X-linked | 1:5.000 | −0.9/−0.6 | Wide variation in height deficit | ↓GH peak during GH stimulation test, ↓IGF-I, ↓IGFBP-3, ↓ALS | GH treatment |
Laron syndrome [262500] | GHR | AR or rarely AD | ≈500 cases | −0.6/−1.6 | Wide variation in height, midfacial hypoplasia | ↑GH, ↓IGF-I, ↓IGFBP-3, ↓ALS, variable GHBP | IGF-I treatment moderately effective |
ALS deficiency [615961] | IGFALS | AR | ≈65 cases | −2.2 | Mild to moderate short stature | ↓IGF-I, ↓IGFBP-3, ↓ALS | No data |
3-M syndrome [273750, 612921, 614205] | CUL7, OBSL1, CCDC8 | AR | ≈200 cases | −3.1 | Facial features, normal mental development, long and slender tubular bones, reduced AP diameter of vertebral bodies, delayed bone age | Nl GH, IGF-I, IGFBP-3 | Effect of GH considered insufficient |
Silver-Russell variant [616489] | IGF2 | AD, paternal | 8 cases | −3.9/−4.6 | Dysmorphic features like SRS, fulfilling the Netchine-Harbison criteria for SRS, including relative macrocephaly | ↑/normal GH, normal IGF-I, ↑/normal IGFBP-3, ↓ IGF-II | GH treatment likely as effective as in other genetic variants of SRS |
Floating Harbor syndrome [136140] | SCRAP | AD | ≈52 cases | −2.5 | Proportionate short stature, delayed bone age and speech, triangular face, deep-set eyes, long eyelashes, bulbous nose, wide columella, short philtrum, thin lips | GH deficiency described in some patients. ↑/normal IGF-I (mainly during rhGH treatment. Nl IGFBP-3 | Insufficient data |
Noonan syndrome [163950] | PTPN11 and 12 other genes | AD or rarely AR | 1:1.000-2.500 | −1.0 | Short stature, facial dysmorphism, wide spectrum of congenital heart defects, pectus deformity, cryptorchidism, coagulation defect | Nl GH, IGFBP-3 ↓/normal IGF-I | GH treatment registered in US and EU |
Monogenic disorders with normal head circumference and disproportionate short stature | |||||||
SHOX-associated short stature [300582] | SHOX | AD | 2-17% of short stature | −0.4 −1.1 | Short forearm and lower leg, bowing of forearm and tibia, dislocation of ulna at elbow, Madelung deformity, muscular hypertrophy, radiologic signs at wrist and forearm | Nl GH, IGF-I, IGFBP-3 | GH has similar efficacy as in Turner syndrome; registered in many countries |
Achondroplasia [100800] | Act FGFR3 | AD | 1:15.000-40.000 | −0.7/−1.0 | Rhizomelic limb shortening, frontal bossing, midface hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, genu varum, trident hand | Nl GH, IGF-I, IGFBP-3 | Effects of GH considered insufficient |
Hypochondro-plasia [146000] | Act FGFR3 | 1:15.000-40.000 | — | Rhizomelic limb shortening, limitation of elbow extension, brachydactyly, relative macrocephaly, generalized laxity, specific radiologic features | Nl GH, IGF-I, IGFBP-3 | Effect of GH considered insufficient | |
Short stature with nonspecific skeletal abnormalities [616255] | NPR2 | AD | 1-2% of short SGA and ISS | −0.8/−2.3 | ↑ sitting height/height ratio, shortening of metacarpals, phenotypic or radiographic indicators of SHOX HI (but no Madelung deformity) | Nl GH, IGF-I, IGFBP-3 | Insufficient data |
Brachydactyly type A1 [1112500] | IHH | AD | 1.6% of short SGA and ISS | −/−1.4 | ↑ sitting height/height ratio, shortening of middle phalanx of 2nd and 5th fingers with cone-shaped epiphyses | Nl GH, IGF-I, IGFBP-3 | Preliminary data GH treatment positive |
Short stature/early-onset osteoarthritis or osteochondritis [165800] | ACAN | AD | 1%-2% of short SGA and ISS | −0.7/−1.5 | Proportionate or disproportionate short stature, with or without advanced bone age, brachydactyly, early-onset osteoarthritis | Nl GH, IGF-I, IGFBP-3 | Insufficient data |
Syndrome [OMIM] . | Genetic defect . | Inheritance . | Incidence . | Mean BW/BL SDS . | Clinical features . | Laboratory data . | Treatment . |
---|---|---|---|---|---|---|---|
Monogenic disorders with normal head circumference and proportionate short stature | |||||||
GH deficiency | GH1, GHRHR, BTK | AR, AD X-linked | 1:5.000 | −0.9/−0.6 | Wide variation in height deficit | ↓GH peak during GH stimulation test, ↓IGF-I, ↓IGFBP-3, ↓ALS | GH treatment |
Laron syndrome [262500] | GHR | AR or rarely AD | ≈500 cases | −0.6/−1.6 | Wide variation in height, midfacial hypoplasia | ↑GH, ↓IGF-I, ↓IGFBP-3, ↓ALS, variable GHBP | IGF-I treatment moderately effective |
ALS deficiency [615961] | IGFALS | AR | ≈65 cases | −2.2 | Mild to moderate short stature | ↓IGF-I, ↓IGFBP-3, ↓ALS | No data |
3-M syndrome [273750, 612921, 614205] | CUL7, OBSL1, CCDC8 | AR | ≈200 cases | −3.1 | Facial features, normal mental development, long and slender tubular bones, reduced AP diameter of vertebral bodies, delayed bone age | Nl GH, IGF-I, IGFBP-3 | Effect of GH considered insufficient |
Silver-Russell variant [616489] | IGF2 | AD, paternal | 8 cases | −3.9/−4.6 | Dysmorphic features like SRS, fulfilling the Netchine-Harbison criteria for SRS, including relative macrocephaly | ↑/normal GH, normal IGF-I, ↑/normal IGFBP-3, ↓ IGF-II | GH treatment likely as effective as in other genetic variants of SRS |
Floating Harbor syndrome [136140] | SCRAP | AD | ≈52 cases | −2.5 | Proportionate short stature, delayed bone age and speech, triangular face, deep-set eyes, long eyelashes, bulbous nose, wide columella, short philtrum, thin lips | GH deficiency described in some patients. ↑/normal IGF-I (mainly during rhGH treatment. Nl IGFBP-3 | Insufficient data |
Noonan syndrome [163950] | PTPN11 and 12 other genes | AD or rarely AR | 1:1.000-2.500 | −1.0 | Short stature, facial dysmorphism, wide spectrum of congenital heart defects, pectus deformity, cryptorchidism, coagulation defect | Nl GH, IGFBP-3 ↓/normal IGF-I | GH treatment registered in US and EU |
Monogenic disorders with normal head circumference and disproportionate short stature | |||||||
SHOX-associated short stature [300582] | SHOX | AD | 2-17% of short stature | −0.4 −1.1 | Short forearm and lower leg, bowing of forearm and tibia, dislocation of ulna at elbow, Madelung deformity, muscular hypertrophy, radiologic signs at wrist and forearm | Nl GH, IGF-I, IGFBP-3 | GH has similar efficacy as in Turner syndrome; registered in many countries |
Achondroplasia [100800] | Act FGFR3 | AD | 1:15.000-40.000 | −0.7/−1.0 | Rhizomelic limb shortening, frontal bossing, midface hypoplasia, exaggerated lumbar lordosis, limitation of elbow extension, genu varum, trident hand | Nl GH, IGF-I, IGFBP-3 | Effects of GH considered insufficient |
Hypochondro-plasia [146000] | Act FGFR3 | 1:15.000-40.000 | — | Rhizomelic limb shortening, limitation of elbow extension, brachydactyly, relative macrocephaly, generalized laxity, specific radiologic features | Nl GH, IGF-I, IGFBP-3 | Effect of GH considered insufficient | |
Short stature with nonspecific skeletal abnormalities [616255] | NPR2 | AD | 1-2% of short SGA and ISS | −0.8/−2.3 | ↑ sitting height/height ratio, shortening of metacarpals, phenotypic or radiographic indicators of SHOX HI (but no Madelung deformity) | Nl GH, IGF-I, IGFBP-3 | Insufficient data |
Brachydactyly type A1 [1112500] | IHH | AD | 1.6% of short SGA and ISS | −/−1.4 | ↑ sitting height/height ratio, shortening of middle phalanx of 2nd and 5th fingers with cone-shaped epiphyses | Nl GH, IGF-I, IGFBP-3 | Preliminary data GH treatment positive |
Short stature/early-onset osteoarthritis or osteochondritis [165800] | ACAN | AD | 1%-2% of short SGA and ISS | −0.7/−1.5 | Proportionate or disproportionate short stature, with or without advanced bone age, brachydactyly, early-onset osteoarthritis | Nl GH, IGF-I, IGFBP-3 | Insufficient data |
Abbreviations: act, activating; AD, autosomal dominant; ALS, acid labile subunit; AR, autosomal recessive; BL, birth length; BW, birth weight; GH, growth hormone; IGF, insulin-like growth factor; IGFBP, IGF binding protein; ISS, idiopathic short stature; SDS, standard deviation score; SGA, small for gestational age; SRS, Silver-Russell syndrome.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.